Part D Rebates: Talking Points Continue, But Deficit Deal Elusive
This article was originally published in RPM Report
Once again the President is calling for rebates on prescription drugs sold under Medicare Part D. But without a big deficit deal involving entitlement reform, is there any way to enact them?
You may also be interested in...
The most recent Congressional Budget Office list of deficit-reducing options includes some familiar items as well as five new approaches to changing health care programs, such as tax-related changes to employer-sponsored insurance.
President Obama’s speech includes some proposals for cost-savings in Medicare, such as having wealthier seniors pay more, moving from pay-for-service to pay-for-performance and mandatory rebates on drugs used in Medicare Part D, which drew a quick response from PhRMA.
Coalition of business leaders that includes Merck CEO Ken Frazier pushes for deficit deal to avert sequestration. The reason seems simple: corporate tax reform.